A phase I study of intravenous (IV) milataxel in combination with carboplatin in adult patients with advanced malignant solid tumors

被引：0
|
作者：
Flood, W. A. [1 ,2 ]
Lewis, L. D. [1 ,2 ]
机构：
[1] Penn State Hershey Canc Inst, Hershey, PA USA
[2] Dartmouth Med Sch, Lebanon, NH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13525
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [42] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Kyriakopoulos, Christos E.
    Braden, Amy M.
    Kolesar, Jill M.
    Eickhoff, Jens C.
    Bailey, Howard H.
    Heideman, Jennifer
    Liu, Glenn
    Wisinski, Kari B.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (03) : 290 - 297
  • [43] Phase I pharmacokinetic (PK) and safety study of intravenous (IV) Cl-1033 in patients with advanced solid tumors
    Simon, GR
    Olson, S
    Garrett, CR
    Eiseman, I
    Langevin, M
    Mahany, JJ
    Sullivan, DM
    Schlicht, MG
    Lush, R
    Lanehan, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 209S - 209S
  • [44] A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
    Liu, Lian
    Zhang, Wen
    Li, Wenhua
    Lv, Fangfang
    Xia, Zuguang
    Zhang, Sheng
    Liu, Wen
    Zandvliet, Anthe S.
    Waajen, Sylvia
    Zhang, Li Xin
    Yan, Li
    Li, Jin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [45] A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
    Lian Liu
    Wen Zhang
    Wenhua Li
    Fangfang Lv
    Zuguang Xia
    Sheng Zhang
    Wen Liu
    Anthe S Zandvliet
    Sylvia Waajen
    Li Xin Zhang
    Li Yan
    Jin Li
    Journal of Hematology & Oncology, 6
  • [46] Phase I study of sunitinib in combination with carboplatin (C) plus paclitaxel (P) in patients (pts) with advanced solid tumors (STs)
    Heath, E. I.
    Blumenschein, G. R., Jr.
    Cohen, R. B.
    LoRusso, P. M.
    LoConte, N. K.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Intravenous administration of ALKS 4230 as monotherapy and in combination with pembrolizumab in a phase I study of patients with advanced solid tumors.
    Vaishampayan, Ulka N.
    Fishman, Mayer N.
    Cho, Daniel C.
    Hoimes, Christopher J.
    Velcheti, Vamsidhar
    McDermott, David F.
    Slichenmyer, William J.
    Putiri, Emily
    Losey, Heather
    Rossi, Sean
    Ernstoff, Marc S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Phase 1, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors
    Patnaik, Amita
    Wood, Debra
    Tolcher, Anthony W.
    Hamilton, Marta
    Kreisberg, Jeffrey I.
    Hammond, Lisa A.
    Schwartz, Garry
    Beeram, Muralidhar
    Hidalgo, Manuel
    Mita, Monica M.
    Wolf, Julie
    Nadler, Paul
    Rowinsky, Eric K.
    CLINICAL CANCER RESEARCH, 2006, 12 (24) : 7406 - 7413
  • [49] Phase I study of ABT-888 in combination with carboplatin and gemcitabine in subjects with advanced solid tumors.
    Bell-McGuinn, Katherine M.
    Gray, Heidi J.
    Fleming, Gini F.
    Cristea, Mihaela C.
    Medina, Diane M.
    Xiong, Hao
    Dudley, Matthew W.
    Dunbar, Martin
    Giranda, Vincent L.
    Luo, Yan
    McKee, Mark D.
    Martin, Lainie P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] A Phase I Study of Chloroquine with Carboplatin and Gemcitabine in Advanced Solid Tumors and NSCLC
    Karim, Nagla Abdel
    Bahassi, El Mustapha
    Khaled, Ahmed
    Shehata, Mahmoud
    Wise-Draper, Trisha
    O'Gara, Sue
    Morris, John
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S430 - S431
12345